Urologists prescribing 5-ARIs should be aware of the recent addition of suicide and [suicidal ideation] risk to the list of side effects. A mental health screen should be performed and appropriate resources provided to patients commencing treatment. Furthermore, a review should be arranged with the general practitioner to assess new-onset mental health or SI symptoms.
—US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know? European Urology Open Science, June 2023